-
Forward Look
Medicare to Cover Lung Cancer ScreeningIn high-risk current and former smokers, screening can reduce cancer deaths.
by Michael Eisenstein
-
Forward Look
Does Testicular Cancer Screening Save Lives?Doctors recommend self-exam, even though guidelines discourage it.
by Roxanne Nelson
-
Genomic Testing: The Risk of Knowing Too Much
Sophisticated tests can generate a wealth of information about a patient's cancer or disease risk. But they also raise serious questions.
by Alexandra Goho
-
A Dose of Precision
Stereotactic radiation therapy–heavily marketed to consumers–is gaining momentum as a more convenient treatment. But it's not for every patient.
by Sharon Reynolds
-
Healthy Habits
A Cup of Tea?Black tea consumption may be associated with a reduced risk of ovarian cancer.
by Kurt Ullman
-
Forward Look
A Champion for PreventionQ&A with Elmer Huerta, the director of the Cancer Preventorium at MedStar Washington Hospital Center
by Sue Rochman
-
Forward Look
National Clinical Trials Network Now UnderwayRevamped program aims to get new treatments to patients faster.
by Michael Eisenstein
-
Forward Look
Personalizing Prostate Cancer TreatmentActive surveillance may not be right for all African-American men with low-grade prostate cancer.
by Stephen Ornes
-
Lighting a Fire Under Tobacco-Related Cancers
As researchers unravel the extent and scientific underpinnings of tobacco-related cancers and addiction, patients can seek support to quit tobacco or cope with the stigma often associated with these cancers.
by Stephen Ornes
-
Telling Cancer’s Story
A Pulitzer Prize-winning book about cancer becomes a documentary after noted filmmaker Ken Burns signs on.
by Marilyn Fenichel
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles